Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment.

Marchiò C, Dell'Orto P, Annaratone L, Geyer FC, Venesio T, Berrino E, Verdun di Cantogno L, Garofoli A, Rangel N, Casorzo L, dell'Aglio C, Gugliotta P, Trisolini E, Beano A, Pietribiasi F, Orlassino R, Cassoni P, Pich A, Montemurro F, Mottolese M, Vincent-Salomon A, Penault-Llorca F, Medico E, Ng CKY, Viale G, Sapino A.

Am J Surg Pathol. 2018 Sep;42(9):1190-1200. doi: 10.1097/PAS.0000000000001100.

2.

Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.

Corso S, Cargnelutti M, Durando S, Menegon S, Apicella M, Migliore C, Capeloa T, Ughetto S, Isella C, Medico E, Bertotti A, Sassi F, Sarotto I, Casorzo L, Pisacane A, Mangioni M, Sottile A, Degiuli M, Fumagalli U, Sgroi G, Molfino S, De Manzoni G, Rosati R, De Simone M, Marrelli D, Saragoni L, Rausei S, Pallabazzer G, Roviello F, Cassoni P, Sapino A, Bass A, Giordano S.

Neoplasia. 2018 May;20(5):443-455. doi: 10.1016/j.neo.2018.02.003. Epub 2018 Mar 23.

3.

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases.

Siravegna G, Geuna E, Mussolin B, Crisafulli G, Bartolini A, Galizia D, Casorzo L, Sarotto I, Scaltriti M, Sapino A, Bardelli A, Montemurro F.

ESMO Open. 2017 Oct 9;2(4):e000253. doi: 10.1136/esmoopen-2017-000253. eCollection 2017.

4.

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.

Apicella M, Migliore C, Capelôa T, Menegon S, Cargnelutti M, Degiuli M, Sapino A, Sottile A, Sarotto I, Casorzo L, Cassoni P, De Simone M, Comoglio PM, Marsoni S, Corso S, Giordano S.

Oncogene. 2017 Mar 2;36(9):1200-1210. doi: 10.1038/onc.2016.283. Epub 2016 Aug 15.

PMID:
27524418
5.

Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient.

Cavalloni G, Peraldo-Neia C, Varamo C, Casorzo L, Dell'Aglio C, Bernabei P, Chiorino G, Aglietta M, Leone F.

Tumour Biol. 2016 Mar;37(3):4041-52. doi: 10.1007/s13277-015-4215-3. Epub 2015 Oct 20.

6.

Aurora kinase A gene copy number is associated with the malignant transformation of colorectal adenomas but not with the serrated neoplasia progression.

Casorzo L, Dell'Aglio C, Sarotto I, Risio M.

Hum Pathol. 2015 Mar;46(3):411-8. doi: 10.1016/j.humpath.2014.11.016. Epub 2014 Dec 10.

PMID:
25596657
7.

Tumour budding is associated with hypoxia at the advancing front of colorectal cancer.

Righi A, Sarotto I, Casorzo L, Cavalchini S, Frangipane E, Risio M.

Histopathology. 2015 Jun;66(7):982-90. doi: 10.1111/his.12602. Epub 2015 Feb 4.

PMID:
25381897
8.

Vulvovaginal angiomyofibroblastomas: morphologic, immunohistochemical, and fluorescence in situ hybridization analysis for deletion of 13q14 region.

Magro G, Righi A, Caltabiano R, Casorzo L, Michal M.

Hum Pathol. 2014 Aug;45(8):1647-55. doi: 10.1016/j.humpath.2014.03.020. Epub 2014 Apr 18.

PMID:
24880711
9.

Mammary and vaginal myofibroblastomas are genetically related lesions: fluorescence in situ hybridization analysis shows deletion of 13q14 region.

Magro G, Righi A, Casorzo L, Antonietta T, Salvatorelli L, Kacerovská D, Kazakov D, Michal M.

Hum Pathol. 2012 Nov;43(11):1887-93. doi: 10.1016/j.humpath.2012.01.015. Epub 2012 May 9.

PMID:
22575260
10.

Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.

Pignochino Y, Sarotto I, Peraldo-Neia C, Penachioni JY, Cavalloni G, Migliardi G, Casorzo L, Chiorino G, Risio M, Bardelli A, Aglietta M, Leone F.

BMC Cancer. 2010 Nov 18;10:631. doi: 10.1186/1471-2407-10-631.

11.

MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors.

Cepero V, Sierra JR, Corso S, Ghiso E, Casorzo L, Perera T, Comoglio PM, Giordano S.

Cancer Res. 2010 Oct 1;70(19):7580-90. doi: 10.1158/0008-5472.CAN-10-0436. Epub 2010 Sep 14.

12.

Derivative (1)t(1;16)(p11;p11.1) in myelodysplastic syndrome: a case report and review of the literature.

Lunghi M, Casorzo L, De Paoli L, Riccomagno P, Rossi D, Gaidano G.

Cancer Genet Cytogenet. 2010 Jan 1;196(1):89-92. doi: 10.1016/j.cancergencyto.2009.07.003. Review.

PMID:
19963141
13.

Evaluation of 7q31 region improves the accuracy of EGFR FISH assay in non small cell lung cancer.

Casorzo L, Corigliano M, Ferrero P, Venesio T, Risio M.

Diagn Pathol. 2009 Nov 4;4:36. doi: 10.1186/1746-1596-4-36.

14.

Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers.

Sangiolo D, Martinuzzi E, Todorovic M, Vitaggio K, Vallario A, Jordaney N, Carnevale-Schianca F, Capaldi A, Geuna M, Casorzo L, Nash RA, Aglietta M, Cignetti A.

Int Immunol. 2008 Jul;20(7):841-8. doi: 10.1093/intimm/dxn042. Epub 2008 May 9.

PMID:
18469328
15.

Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis.

Casorzo L, Luzzi C, Nardacchione A, Picciotto F, Pisacane A, Risio M.

Melanoma Res. 2005 Jun;15(3):155-60.

PMID:
15917696
16.

HER2 gene-amplified breast cancers with monosomy of chromosome 17 are poorly responsive to trastuzumab-based treatment.

Risio M, Casorzo L, Redana S, Montemurro F.

Oncol Rep. 2005 Feb;13(2):305-9.

PMID:
15643516
17.

HER2 and central nervous system metastasis in patients with breast cancer.

Montemurro F, Sarotto I, Casorzo L, Pisacane A, Aglietta M, De Rosa G.

Clin Breast Cancer. 2004 Aug;5(3):232-4.

PMID:
15335457
18.

Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses.

Cignetti A, Vallario A, Roato I, Circosta P, Allione B, Casorzo L, Ghia P, Caligaris-Cappio F.

J Immunol. 2004 Aug 15;173(4):2855-65.

19.

Deletions of 17p are associated with transition from early to advanced colorectal cancer.

Risio M, Casorzo L, Chiecchio L, De Rosa G, Rossini FP.

Cancer Genet Cytogenet. 2003 Nov;147(1):44-9.

PMID:
14580770
20.

HER2 testing in gastric cancer: molecular morphology and storage time-related changes in archival samples.

Risio M, De Rosa G, Sarotto I, Casorzo L, Capussotti L, Torchio B, Aglietta M, Chiecchio L.

Int J Oncol. 2003 Nov;23(5):1381-7.

PMID:
14532980
21.

Cytogenetic findings in a case of dedifferentiated chondrosarcoma.

Casorzo L, Chiecchio L, Pisacane A, Fumero S, Canavese F, Torchio B, Risio M.

Cancer Genet Cytogenet. 2003 Jul 1;144(1):61-4.

PMID:
12810257
22.

Gastrointestinal stromal tumor, uncommitted type, with monosomies 14 and 22 as the only chromosomal abnormalities.

Marci V, Casorzo L, Sarotto I, Dogliani N, Milazzo MG, Risio M.

Cancer Genet Cytogenet. 1998 Apr 15;102(2):135-8.

PMID:
9546066
23.

Extraskeletal Ewing's tumor with translocation t(11;22) in a patient with Down syndrome.

Casorzo L, Fessia L, Sapino A, Ponzio G, Bussolati G.

Cancer Genet Cytogenet. 1989 Jan;37(1):79-84.

PMID:
2521811

Supplemental Content

Loading ...
Support Center